ORG Wealth Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

ORG Wealth Partners’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42	Hold	1	–	–	﹤0.01%	683
2026 Q1	$26	Buy	+1	New	+$29	﹤0.01%	649

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

ORG Wealth Partners's ARKG Position: Q2 2026 in Review

ORG Wealth Partners held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 1 share worth $42. The position accounts for ﹤0.01% of the portfolio, ranked #683.

ORG Wealth Partners first reported a position in ARKG in Q1 2026 and has held it in 2 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

ORG Wealth Partners held 1 share of ARK Genomic Revolution ETF worth $42 as of Q2 2026.
ORG Wealth Partners left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of ORG Wealth Partners's portfolio in Q2 2026, its #683 holding.
ORG Wealth Partners first reported a position in ARK Genomic Revolution ETF in Q1 2026 and has held it in 2 quarters since.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on ORG Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.